Derivative exercise or conversion — not an open-market buy.
Traded Feb 12, 2026 · Filed Feb 13, 2026
A board member of Cognex sold $10.1M of Cognex shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$10,117,904
Shares × reported transaction price
1 day after results of Feb 11, 2026, 83 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.4% | +0.7% | +0.7% |
| 30 days | −12.0% | −3.4% | −8.6% |
| 90 days | +8.4% | +8.2% | +0.3% |
| 180 days | +16.7% | +13.2% | +3.5% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
A board member of Cognex sold $135K of Cognex shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.